Clinical Trial Update: PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating preoperative chemoradiation with either paclitaxel-carboplatin or FOLFOX for resectable esophageal and gastroesophageal junction canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CARBOPLATIN (Carboplatin)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Esophageal Neoplasms, Gastro-esophageal Junction Cancer | Phase 2 | Status: COMPLETED